CAS RN: 1595129-71-7
ME401
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250712
10mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1595129-71-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1595129-71-7 / N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-4-(2-methylsulfonylbenzimidazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-amine
Standard CAS: 1595129-71-7
Multi CAS: No
Basic Information
copy
CAS
1595129-71-7 copy
Multi CAS
No copy
Molecular Formula
C31H40N8O3S copy
Molecular Weight
604.800000 copy
Exact Mass
604.294408 copy
SMILES
CC(C)(CC1=CC=CC=C1C2CCN(CC2)C)NC3=NC(=NC(=N3)N4CCOCC4)N5C6=CC=CC=C6N=C5S(=O)(=O)C copy
InChI
InChI=1S/C31H40N8O3S/c1-31(2,21-23-9-5-6-10-24(23)22-13-15-37(3)16-14-22)36-27-33-28(38-17-19-42-20-18-38)35-29(34-27)39-26-12-8-7-11-25(26)32-30(39)43(4,40)41/h5-12,22H,13-21H2,1-4H3,(H,33,34,35,36) copy
InChIKey
PGTXVGREXBMCCY-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
43 copy
Aromatic heavy atom count
21 copy
Fraction Csp3
0.48 copy
Rotatable bonds
8 copy
H-bond acceptors
11 copy
H-bond donors
1 copy
Molar refractivity
167.92 copy
TPSA
118.37 copy
LogP / Solubility
WLOGP
3.69 copy
MLOGP
3.3 copy
XLogP3
4.6 copy
Consensus LogP
3.86 copy
Log S (ESOL)
-5.75 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-7.19 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-7.62 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.79 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.56 copy
Leadlikeness
No copy
Synthetic Accessibility
5.5 copy